Baxter is restarting manufacturing of IV solutions at the North Cove plant ahead of the company's original expectations, the company said. And, company executives credited the "urgency ...
Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...
Baxter International Inc.’s Marion plant is now producing a limited amount of IV solutions, the manufacturer said Thursday. Baxter has restarted production on the line that produces the largest ...
Baxter International Inc.’s Marion plant is now producing a limited amount of IV solutions, the manufacturer said Thursday. Baxter has restarted production on the line that produces the largest ...